112 related articles for article (PubMed ID: 3610710)
21. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
Kirichenko AV; Rich TA; Newman RA; Travis EL
Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
[TBL] [Abstract][Full Text] [Related]
23. [Mannatide enhances the efficacy of fractionated and unfractionated radiotherapy in mice bearing Lewis lung cancer].
Fan RT; Hu Y; Liu JQ; Zhang JJ; Song R; Gu H
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2072-5. PubMed ID: 22200715
[TBL] [Abstract][Full Text] [Related]
24. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.
Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Korbut TT
Cancer Res; 1990 Jul; 50(13):3826-31. PubMed ID: 2354434
[TBL] [Abstract][Full Text] [Related]
25. Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo.
Teicher BA; Wong JS; Takeuchi H; Gravelin LM; Ara G; Buxton D
Cancer Chemother Pharmacol; 1998; 42(1):24-30. PubMed ID: 9619754
[TBL] [Abstract][Full Text] [Related]
26. Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: a preliminary report.
Brown JM; Yu NY
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1207-12. PubMed ID: 6236184
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo.
Brown JM
Radiat Res; 1977 Dec; 72(3):469-86. PubMed ID: 594322
[No Abstract] [Full Text] [Related]
28. In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation.
Sasai K; Fushiki M; Yukawa Y; Suyama S; Iwai H; Shibamoto Y; Nishimoto S; Takahashi M; Abe M
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1231-4. PubMed ID: 1938521
[TBL] [Abstract][Full Text] [Related]
29. NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation.
Denny WA; Roberts PB; Anderson RF; Brown JM; Phil D; Wilson WR
Int J Radiat Oncol Biol Phys; 1992; 22(3):553-6. PubMed ID: 1735695
[TBL] [Abstract][Full Text] [Related]
30. Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C.
Herman TS; Teicher BA; Holden SA
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):375-82. PubMed ID: 2105922
[TBL] [Abstract][Full Text] [Related]
31. [Radiosensitization of Lewis lung tumor by perfluorochemical emulsion comparison between single and fractionated irradiation].
Hishikawa-itoh Y; Miyata N
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):781-7. PubMed ID: 2142500
[TBL] [Abstract][Full Text] [Related]
32. Sensitizers and radiation dose fractionation: results and interpretations.
Hill RP
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1049-54. PubMed ID: 2943705
[TBL] [Abstract][Full Text] [Related]
33. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer.
Sasai K; Nishimoto S; Shimokawa K; Hisanaga Y; Kitakabu Y; Shibamoto Y; Zhou L; Wang J; Takahashi M; Kagiya T
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1249-54. PubMed ID: 1828462
[TBL] [Abstract][Full Text] [Related]
34. Combinations of CCNU, MISO, and fractionated radiotherapy.
Siemann DW; Alliet KL
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1379-82. PubMed ID: 3759559
[TBL] [Abstract][Full Text] [Related]
35. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
Yuan X; Tabassi K; Williams JA
Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
Dorie MJ; Menke D; Brown JM
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
[TBL] [Abstract][Full Text] [Related]
37. Effects of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DA.
Teicher BA; Rose CM
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1311-3. PubMed ID: 3093415
[TBL] [Abstract][Full Text] [Related]
38. Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour.
Hill SA; Fowler JF
Br J Cancer; 1977 Apr; 35(4):461-9. PubMed ID: 869984
[TBL] [Abstract][Full Text] [Related]
39. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
40. Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule.
Cividalli A; Ceciarelli F; Livdi E; Altavista P; Cruciani G; Marchetti P; Danesi DT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1092-8. PubMed ID: 11958906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]